Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Hemostatic Disorders
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Hemorrhagic Disorders » Hemostatic Disorders
Description
Pathological processes involving the integrity of blood circulation. Hemostasis depends on the integrity of BLOOD VESSELS, blood fluidity, and BLOOD COAGULATION. Majority of the hemostatic disorders are caused by disruption of the normal interaction between the VASCULAR ENDOTHELIUM, the plasma proteins (including BLOOD COAGULATION FACTORS), and PLATELETS. MeSH
Hierarchy View
Subtype Terms (11)
Cryoglobulinemia
7 approved drugs
Ehlers-Danlos Syndrome
6 drugs (4 approved, 2 experimental)
IgA Vasculitis
16 drugs (12 approved, 4 experimental)
Multiple Myeloma
836 drugs (294 approved, 542 experimental)
Pseudoxanthoma Elasticum
6 drugs (4 approved, 2 experimental)
Scurvy
1 approved drug
Telangiectasia, Hereditary Hemorrhagic
17 drugs (13 approved, 4 experimental)
Waldenstrom Macroglobulinemia
168 drugs (94 approved, 74 experimental)
Approved Indicated Drugs (1)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (28)
Organization Involved with Phase 3 Indications (52)
Bataillon des marins pompiers de Marseille, France
Direction Centrale du Service de Santé des Armées
Health Research Council, New Zealand
Hospital center of Annecy Genevois,France
Icahn School of Medicine at Mount Sinai
Institut de Recherche Biomedicale des Armees
Organization Involved with Phase 2 Indications (17)
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (12)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
